RPG Life Sciences buys Raghava API unit for up to Rs 135 crore
RPG Life Sciences acquired Raghava Life Sciences’ active pharmaceutical ingredients and intermediates business for up to Rs 135 crore, its second acquisition in just over a month.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.